Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | RO6839921 |
Trade Name | |
Synonyms | RO-6839921 |
Drug Descriptions |
RO6839921 is a pegylated prodrug of idasanutlin that binds to MDM2 and inhibits its interaction with p53, preventing degradation of p53, thereby potentially resulting in restoration of wild-type p53 activity and apoptosis of tumor cells (PMID: 31734832, PMID: 32020437). |
DrugClasses | MDM2 Inhibitor 23 |
CAS Registry Number | NA |
NCIT ID | C114980 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cytarabine + RO6839921 | Cytarabine RO6839921 | 1 | 0 |
Pegylated liposomal doxorubicin + RO6839921 | Pegylated liposomal doxorubicin RO6839921 | 1 | 0 |
RO6839921 | RO6839921 | 1 | 1 |